Featured Archives - Pattern Bioscience

Pattern Bioscience Receives FDA Breakthrough Device Designation for Urine ID/AST Panel

by Eric Berger | Sep 21, 2026 | Featured • Press Releases

Designation advances the company’s Urine (UTI) ID/AST Panel on Pattern’s single-cell microbiology platform. AUSTIN, Texas, September 21, 2026 — Pattern Bioscience, an innovator in rapid diagnostic technologies for bacterial infections, today announced that the U.S....

Pattern Bioscience Appoints David Barreca as Vice President of Sales

by Eric Berger | Jul 27, 2026 | Featured • Press Releases

Commercial leader in diagnostics joins Pattern to build US sales organization as the company nears FDA submission of its breakthrough single-cell microbiology platform and launch of the Pneumonia ID/AST Panel. AUSTIN, Texas, July 27, 2026 — Pattern Bioscience, an...

Pattern Bioscience Surpasses 1,000 Samples in Multi-Center Clinical Trial of Rapid Pneumonia Diagnostic

by Kyle Fieleke | Mar 19, 2026 | Featured • Press Releases

Milestone marks the half-way point of enrollment in pivotal U.S. study designed to support 510(k) submission for the first culture-free, rapid phenotypic ID/AST panel for critically ill pneumonia patients AUSTIN, Texas, March 19, 2026 — Pattern Bioscience, an...

Pattern Awarded $22.5M BARDA Contract to Advance Single-Cell Microbiology System and Critical Care Antimicrobial Susceptibility Testing Panels for Pneumonia and Bacteremia

by Kyle Fieleke | Nov 21, 2024 | Featured • Press Releases

Austin, TX – November 21, 2024 – Pattern Bioscience, an innovator in rapid diagnosis and antibiotic susceptibility testing for bacterial infections, today announced it has been awarded a cost-share contract worth up to $40.9 million by the Biomedical Advanced Research...

Pattern Bioscience Selected as Winner of ADLM Disruptive Technology Award

by Kyle Fieleke | Jul 31, 2023 | Featured • Press Releases

AUSTIN, Texas — July 31, 2023 — Pattern Bioscience, Inc., an innovator in rapid diagnosis and antibiotic susceptibility testing (AST) for bacterial infections, today announced that it was named the winner of the Disruptive Technology Award from the Association for...

Pattern Bioscience Appoints Carey-Ann Burnham as Chief Clinical Officer

by Kyle Fieleke | Mar 10, 2022 | Featured • Press Releases

Renowned microbiologist will bring clinical expertise as the company advances its platform for rapid pathogen identification and antibiotic susceptibility testing AUSTIN, Texas — March 10, 2022 — Pattern Bioscience, Inc., developer of Digital Culture™ technology for...

« Older Entries